Sienna Biopharmaceuticals, Inc. (SNNA)

Trade SNNA now with
10/7/2019 8:40:26 AM Sienna Biopharma Files 510(k) Submission With FDA For SNA-001
9/17/2019 8:39:05 AM Sienna Biopharmaceuticals To File Voluntary Petition For Chapter 11 Bankruptcy
2/20/2019 8:20:43 AM Sienna Biopharma Prices Public Offering Of 8 Mln Shares At $2.50/Shr
2/8/2019 9:15:41 AM Sienna’ Novel Silver Photoparticle Tech SNA-001 Removes Light Hair When Used With Common Laser System
8/9/2018 9:07:01 AM Sienna Biopharma Q2 Loss/shr $1.00 Vs. Loss/shr $6.50 Prior Year
8/2/2018 9:08:20 AM Sienna Biopharma Appoints James Hindman To Board
7/24/2018 9:06:13 AM Sienna Successfully Completes Maximal Use Safety Study Of SNA-120 In Patients With Itch Associated With Psoriasis
7/2/2018 9:06:26 AM Sienna Biopharmaceuticals Enters $40 Mln Term Loan Agreement With Silicon Valley Bank
3/22/2018 8:05:46 AM Sienna Biopharmaceuticals Appoints Caroline Van Hove As Its First Chief Commercial Officer
3/12/2018 6:13:38 AM Sienna Biopharma Announces First Patient Dosed In Proof-of-Concept Trial Of Topical By Design JAK Inhibitor SNA-125